Biktarvy, formally known as bictegravir sulfate, is a powerful single-tablet treatment for managing HIV infection. This drug unites three crucial antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by preventing the virus's ability to replicate within the body, remarkably reducing the viral burden. For many in